DOH gives go-signal on recruitment of participants for Avigan clinical trial
The Department of Health (DOH) said at a press briefing that the agency gave the go-signal to recruit participants for the clinical trial of Japanese medicine Avigan.
This, as DOH said that the department was hopeful that the clinical trial for Avigan — a Japanese medicine that could treat coronavirus (COVID-19) patients — would begin soon.
DOH Undersecretary Maria Rosario Vergeire said at a press briefing that the proponents of the clinical trial only had to settle some minor issues about the “insurance documents”.
“That’s the only thing (remaining), but we already gave the go-signal to the proponents. They are now going to start recruiting participants for the trial”, Vergeire said.
READ ALSO: Clinical Trials For Avigan Eyed To Begin This Week
The nine-month clinical trial was supposed to begin last August, but some documentary requirements had to be completed first.
It was last August when the DOH received Avigan that was good for 100 participants. The four hospitals involved in the clinical trial of Avigan were the following: Sta. Ana Hospital, Philippine General Hospital, Quirino Memorial Medical Center, and Dr. Jose Rodriguez Memorial Hospital.
As of 4:00 p.m. of October 9, 2020, the Department of Health recorded a total of 334,770 cases of coronavirus disease (COVID-19), including 6,152 total deaths, 275,307 total recoveries, and 53,311 total active cases.
For more updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via official Facebook page and YouTube channel.
